Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Ibrutinib

EU orphan designation number: EU/3/16/1780   
Active ingredient: Ibrutinib
Indication: Treatment of graft-versus-host disease
Sponsor: Janssen-Cilag International NV
Turnhoutseweg 30, B-2340 Beerse, België

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/11/2016 Orphan designation EMA/OD/178/16 (2016)7623 of 18/11/2016